Penny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer CandidatesBenzinga • 10/08/24
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate UpdatesGlobeNewsWire • 10/07/24
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/14/24
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsGlobeNewsWire • 04/26/24
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and WarrantsGlobeNewsWire • 04/25/24
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024GlobeNewsWire • 04/08/24
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateGlobeNewsWire • 03/29/24
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024GlobeNewsWire • 03/05/24
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in LymphomaGlobeNewsWire • 01/07/24
Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/14/23
Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023GlobeNewsWire • 09/19/23
Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943GlobeNewsWire • 09/14/23
Vincerx Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/07/23
Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/11/23
Vincerx Pharma Presents Preclinical Data on VIP924, a First-in-Class Antibody-Drug Conjugate (ADC), at the 2023 American Association for Cancer Research (AACR) Annual MeetingGlobeNewsWire • 04/19/23
Vincerx Pharma Presents Preclinical Data on Novel Small Molecule Drug Conjugates at the American Association for Cancer Research (AACR) Annual Meeting 2023GlobeNewsWire • 04/17/23